Skip to main content

Advertisement

Table 1 Demographic Data

From: Perioperative and long-term operative outcomes after surgery for trigeminal neuralgia: microvascular decompression vs percutaneous balloon ablation

  BA MVD
Age (years) 66.1 ± 1.5 55.6 ± 1.6 *
Gender (%)   
   Male 33(39%) 37(46%)
   Female 51(61%) 43(54%)
ASA Physical Status (%)   
   1 8 13
   2 69 67
   3 20 19
   4 2 1
Disease Length (Years) 7.0 ± 0.8 (0.3 – 40) 5.3 ± 0.7 (0.3 – 32)
Number of Medications **   
   0 7 1
   1 48 43
   2 36 38
   3 or > 11 19
Incidence of Pre-operative Trigger Point Injections (%) 13.1 3.8 *
Incidence of prior surgery for TN (%) 26 28
  1. * P < 0.05 compared to BA
  2. All data reported as mean ± SEM, ** Medications use perioperatively include: Carbemazepine, Phenytoin, Baclofen, Neurontin, Depakote) used pre-operatively (%)